photo of

Details

Role Clinical Geneticist
Group Clinical Services
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of...
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.

Top Publications

  • Milne, SC, Hocking, DR, Georgiou-Karistianis, N, Murphy, A, Delatycki, MB, Corben, LA. Sensitivity of spatiotemporal gait parameters in measuring disease severity in Friedreich ataxia.. Cerebellum 13(6) : 677 -688 2014
    view publication
  • Delatycki, MB, Burke, J, Christie, L, Collins, F, Gabbett, M, George, P, Haan, E, Ioannou, L, Martin, N, McKenzie, F, et al. Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis.. Twin Res Hum Genet 17(6) : 578 -583 2014
    view publication
  • Massie, J, Ioannou, L, Delatycki, M. Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?. Aust N Z J Obstet Gynaecol 54(6) : 503 -509 2014
    view publication
  • Corben, LA, Lynch, D, Pandolfo, M, Schulz, JB, Delatycki, MB, Clinical Management Guidelines Writing Group. Consensus clinical management guidelines for Friedreich ataxia.. Orphanet J Rare Dis 9: 184 2014
    view publication
  • Lessel, D, Vaz, B, Halder, S, Lockhart, PJ, Marinovic-Terzic, I, Lopez-Mosqueda, J, Philipp, M, Sim, JCH, Smith, KR, Oehler, J, et al. Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features.. Nat Genet 46(11) : 1239 -1244 2014
    view publication